37.13

37.13 (0.49%)

As of Mar 01, 2024

COLLEGIUM PHARMACEUTICAL, INC [COLL]

Source: 

Company Overview

Collegium Pharmaceutical, Inc are building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. We commercialize our pain portfolio, consisting of Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic, in the United States.

CountryUS
Headquartersstoughtonmassachusetts
Phone Number(781) 713-3699
Industrypharmaceutical preparations
CEOJoseph Ciaffoni
Websitewww.collegiumpharma.com